158 related articles for article (PubMed ID: 38680262)
21. Thrombophilia: Testing rarely useful after a venous thromboembolic event.
Prescrire Int; 2017 May; 26(182):129. PubMed ID: 30730674
[TBL] [Abstract][Full Text] [Related]
22. [Venous thromboembolic disease: which coagulation screening, for whom, when?].
Wautrecht JC
Rev Med Brux; 2005 Sep; 26(4):S315-9. PubMed ID: 16240880
[TBL] [Abstract][Full Text] [Related]
23. Protein C and protein S deficiency - practical diagnostic issues.
Wypasek E; Undas A
Adv Clin Exp Med; 2013; 22(4):459-67. PubMed ID: 23986205
[TBL] [Abstract][Full Text] [Related]
24. Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment.
Marlar RA; Mastovich S
Blood Coagul Fibrinolysis; 1990 Aug; 1(3):319-30. PubMed ID: 2103316
[TBL] [Abstract][Full Text] [Related]
25. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism.
Brenner B; Bikdeli B; Tzoran I; Madridano O; López-Reyes R; Suriñach JM; Blanco-Molina Á; Tufano A; Núñez JJL; Trujillo-Santos J; Monreal M;
Am J Med; 2018 Sep; 131(9):1095-1103. PubMed ID: 29807000
[TBL] [Abstract][Full Text] [Related]
26. Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.
Ichiyama M; Ohga S; Ochiai M; Tanaka K; Matsunaga Y; Kusuda T; Inoue H; Ishimura M; Takimoto T; Koga Y; Hotta T; Kang D; Hara T
Pediatr Res; 2016 Jan; 79(1-1):81-6. PubMed ID: 26372516
[TBL] [Abstract][Full Text] [Related]
27. Acute Myocardial Infarction as an Initial Presentation of Protein C and Protein S Deficiency Followed by Dilated Cardiomyopathy in a Young Male.
Tahir F; Majid Z; Majid B; Khan S
Cureus; 2019 Apr; 11(4):e4492. PubMed ID: 31259110
[TBL] [Abstract][Full Text] [Related]
28. Prothrombotic abnormalities in children with venous thromboembolism.
Bonduel M; Hepner M; Sciuccati G; Torres AF; Pieroni G; Frontroth JP
J Pediatr Hematol Oncol; 2000; 22(1):66-72. PubMed ID: 10695825
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
30. Venous thrombosis in older people: prevalence of the factor V gene mutation Q506.
André E; Siguret V; Alhenc-Gelas M; Saint-Jean O; Gaussem P
J Am Geriatr Soc; 1998 Dec; 46(12):1545-9. PubMed ID: 9848816
[TBL] [Abstract][Full Text] [Related]
31. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
Friederich PW; Sanson BJ; Simioni P; Zanardi S; Huisman MV; Kindt I; Prandoni P; Büller HR; Girolami A; Prins MH
Ann Intern Med; 1996 Dec; 125(12):955-60. PubMed ID: 8967705
[TBL] [Abstract][Full Text] [Related]
32. [Protein C dynamics in peripheral arterial occlusive diseases and myocardial infarction: association of homozygous protein C deficiency with heterozygous dysplasminogenemia found among patients with deep vein thrombosis].
Manabe S
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):220-30. PubMed ID: 3754930
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
[TBL] [Abstract][Full Text] [Related]
34. [A sporadic case of protein C deficiency].
Ishimaru F; Hayashi H; Ueki K; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1990 Nov; 31(11):1856-61. PubMed ID: 2287072
[TBL] [Abstract][Full Text] [Related]
35. Protein C Deficiency.
Dinarvand P; Moser KA
Arch Pathol Lab Med; 2019 Oct; 143(10):1281-1285. PubMed ID: 30702334
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
37. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
38. Congenital prothrombotic disorders in children with peripheral venous and arterial thromboses.
Albisetti M; Moeller A; Waldvogel K; Bernet-Buettiker V; Cannizzaro V; Anagnostopoulos A; Balmer C; Schmugge M
Acta Haematol; 2007; 117(3):149-55. PubMed ID: 17159337
[TBL] [Abstract][Full Text] [Related]
39. The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease.
Kuy S; Dua A; Chappidi R; Seabrook G; Brown KR; Lewis B; Rossi PJ; Lee CJ
Vascular; 2015 Jun; 23(3):260-4. PubMed ID: 24986868
[TBL] [Abstract][Full Text] [Related]
40. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
O'Connell KA; Wood JJ; Wise RP; Lozier JN; Braun MM
JAMA; 2006 Jan; 295(3):293-8. PubMed ID: 16418464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
